Chemerin as a marker of subclinical cardiac involvement in psoriatic patients

Aksu F., ÇALIŞKAN M., Keles N., Toprak A. E., Uzuncakmak T. K., Kostek O., ...More

CARDIOLOGY JOURNAL, vol.24, no.3, pp.276-283, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 24 Issue: 3
  • Publication Date: 2017
  • Doi Number: 10.5603/cj.a2017.0031
  • Journal Name: CARDIOLOGY JOURNAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
  • Page Numbers: pp.276-283
  • Keywords: chemerin, flow-mediated dilatation, epicardial fat tissue, psoriasis, C-REACTIVE PROTEIN, ENDOTHELIAL FUNCTION, CARDIOVASCULAR RISK, METABOLIC SYNDROME, ATHEROSCLEROSIS, DYSFUNCTION, FAT, INFLAMMATION, ASSOCIATION, DISEASE
  • Marmara University Affiliated: No

Abstract

Background: Chemerin has been associated with psoriasis and inflammation, but there are no studies demonstrating an association between chemerin and subclinical cardiac involvement in psoriatic patients. Therefore, the present study aimed to evaluate whether psoriatic patients with increased epicardial fat tissue, impaired flow-mediated dilatation, and diastolic dysfunction have higher serum chemerin levels than a healthy control group.